» Articles » PMID: 36015243

Swiss Medical Devices for Autologous Regenerative Medicine: From Innovation to Clinical Validation

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2022 Aug 26
PMID 36015243
Authors
Affiliations
Soon will be listed here.
Abstract

Regenerative medicine, based on the use of autologous tissues and embryonic, stem or differentiated cells, is gaining growing interest. However, their preparation, in a manner compliant with good practices and health regulations, is a technical challenge. The aim of this manuscript is to present the design of reliable CE marked medical devices for the preparation of standardized platelet-rich plasma (PRP) and other autologous biologics intended for therapeutic uses. There are numerous PRP isolation processes. Depending on the methodology used, PRP composition varies greatly in terms of platelet concentration, platelet quality, and level of contamination with red and white blood cells. This variability in PRP composition might affect the clinical outcomes. The devices presented here are based on a specific technology, patented all over the world, that allows the precise separation of blood components as a function of their density using thixotropic separator gels in closed systems. This allows the preparation, in an automated manner, of leukocyte poor PRP with a standardized composition. Production of different forms of PRP is a clinical asset to suit various therapeutic needs. Therefore, we are offering solutions to prepare PRP either in liquid or gel form, and PRP combined with hyaluronic acid. These biologics have been successfully used in many different therapeutic domains, resulting in more than 150 published clinical studies. We also developed the CuteCell technology platform for cell culture expansion for further autologous cell therapies. This technology enables the safe and rapid in vitro expansion of cells intended for therapeutic use in good manufacturing practices (GMP) and autologous conditions, using blood-derived products as culture media supplementation. We summarize in this article our 20 years' experience of research and development for the design of PRP devices and, more recently, for PRP combined with hyaluronic acid.

Citing Articles

Enhancing Endometrial Health in Assisted Reproductive Technology (ART): Evaluating Autologous Endometrial Cells and Platelets-Rich Plasma (PRP) via Hysteroscopic Injections.

Karadbhajne P, More A, Dzoagbe H Cureus. 2024; 16(7):e64068.

PMID: 39114217 PMC: 11305442. DOI: 10.7759/cureus.64068.


Platelet-Rich Plasma Promotes the Expansion of Human Myoblasts and Favors the In Vitro Generation of Human Muscle Reserve Cells in a Deeper State of Quiescence.

Tollance A, Prola A, Michel D, Bouche A, Turzi A, Hannouche D Stem Cell Rev Rep. 2024; 20(7):1981-1994.

PMID: 39001964 PMC: 11445347. DOI: 10.1007/s12015-024-10760-0.


Response to the Commentary on: Safety and feasibility of percutaneous needle tunneling with platelet-rich plasma injections for Peyronie's disease in the outpatient setting: a pilot study.

Zugail A, Alshuaibi M, Beley S Int J Impot Res. 2024; 36(3):299-300.

PMID: 38580726 DOI: 10.1038/s41443-024-00874-x.


How to make full use of dental pulp stem cells: an optimized cell culture method based on explant technology.

Wu Y, Sun J, Wang W, Wang Y, Friedrich R Front Bioeng Biotechnol. 2024; 12:1324049.

PMID: 38562666 PMC: 10982513. DOI: 10.3389/fbioe.2024.1324049.


Recent Achievements in the Development of Biomaterials Improved with Platelet Concentrates for Soft and Hard Tissue Engineering Applications.

Grzelak A, Hnydka A, Higuchi J, Michalak A, Tarczynska M, Gaweda K Int J Mol Sci. 2024; 25(3).

PMID: 38338805 PMC: 10855389. DOI: 10.3390/ijms25031525.


References
1.
Karasavvidis T, Totlis T, Gilat R, Cole B . Platelet-Rich Plasma Combined With Hyaluronic Acid Improves Pain and Function Compared With Hyaluronic Acid Alone in Knee Osteoarthritis: A Systematic Review and Meta-analysis. Arthroscopy. 2020; 37(4):1277-1287.e1. DOI: 10.1016/j.arthro.2020.11.052. View

2.
Brancato S, Albina J . Wound macrophages as key regulators of repair: origin, phenotype, and function. Am J Pathol. 2011; 178(1):19-25. PMC: 3069845. DOI: 10.1016/j.ajpath.2010.08.003. View

3.
Oh J, Kim W, Park K, Roh Y . Comparison of the Cellular Composition and Cytokine-Release Kinetics of Various Platelet-Rich Plasma Preparations. Am J Sports Med. 2015; 43(12):3062-70. DOI: 10.1177/0363546515608481. View

4.
Boswell S, Cole B, Sundman E, Karas V, Fortier L . Platelet-rich plasma: a milieu of bioactive factors. Arthroscopy. 2012; 28(3):429-39. DOI: 10.1016/j.arthro.2011.10.018. View

5.
Hersant B, SidAhmed-Mezi M, La Padula S, Niddam J, Bouhassira J, Meningaud J . Efficacy of Autologous Platelet-rich Plasma Glue in Weight Loss Sequelae Surgery and Breast Reduction: A Prospective Study. Plast Reconstr Surg Glob Open. 2016; 4(11):e871. PMC: 5142469. DOI: 10.1097/GOX.0000000000000823. View